Subject category:
Finance, Accounting and Control
Published by:
Ivey Publishing
Version: 2006-02-14
Share a link:
https://casecent.re/p/14738
Write a review
|
No reviews for this item
This product has not been used yet
Abstract
Merix Bioscience is a biotechnology company that researches and develops cancer vaccines. An investment analyst for a venture capital fund must evaluate whether or not to recommend participation in a second round of financing for the company. The analyst must assess the company''s strengths and weaknesses, the value of shares and determine the key clauses of the term sheet.
About
Abstract
Merix Bioscience is a biotechnology company that researches and develops cancer vaccines. An investment analyst for a venture capital fund must evaluate whether or not to recommend participation in a second round of financing for the company. The analyst must assess the company''s strengths and weaknesses, the value of shares and determine the key clauses of the term sheet.